CureDM
A biopharmaceutical company focused on the development therapies to prevent, ameliorate and reverse diabetes
1
Funding Rounds
$2.5m
Money raised
Overview
A biopharmaceutical company focused on the development therapies to prevent, ameliorate and reverse diabetes
- Website:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Lo** V. Up*** | - | - | - |
Funding series
Funding Series Analysis
The company CureDM has raised a total of $2.5m in funding over 1 rounds.
Key Insights:
- CureDM Series B round: $2.5m
CureDM Series B round
$2.5m